Cell
Transplants Singapore Pte. Ltd. was established in February 2000, as
a subsidiary of Cell Transplants International. It is the first myoblast production
facility set up outside the U.S. and targeted to serve the Asian Pacific region.
Located
at the Alpha in Science Park II, CTS occupies a space of 5,000 sq ft and is
fully equipped to provide a cGMP, and ISO9001 certified facility for the following:
-
Class 10,000 cleanroom for Cell Culture Production
-
Class 10,000 cleanroom for Medium and Buffer Preparation
-
QC Laboratory
-
Cryopreservation Facility
- Cold Room for Medium
and Buffer Storage
- Receiving and Quarantine
Area
- Material Storage and
Inventory
- Autoclaving and Utility
Areas
With a team of dedicated
scientists and personnel skilled in cell manufacturing and quality assurance/quality
control, the CTS facility is able to produce pure myoblasts by the billions
for research and treatment.
CELL
TRANSPLANTS SINGAPORE PTE. LTD.
As
the demand for the new MTT procedure increases, new centers for Myoblast Transfer
Therapy are being established worldwide.